Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244374 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
NCT00244374 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 546 participants.
The verdict
NCT00244374, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
Interventions
- BIOLOGICAL Hepatitis A & B vaccine
- BEHAVIORAL Outreach
- BEHAVIORAL AIC
- BEHAVIORAL SEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00244374
The ClinicalTrials.gov registry entry for NCT00244374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Hepatitis A & B vaccine is the first listed.
NCT00244374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00244374 about?
NCT00244374 is a clinical study titled "A Randomized Trial of Vaccine Adherence in Young Injection Drug Users". The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
What is the current status of trial NCT00244374?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2004-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00244374?
The interventions under investigation include: Hepatitis A & B vaccine (BIOLOGICAL), Outreach (BEHAVIORAL), AIC (BEHAVIORAL), SEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT00244374?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.